Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Because it specifically targets beta-3 receptors, AOD-9604 focuses on fat cells and avoids the broader metabolic effects of full-length growth hormone, making it especially useful for studying fat metabolism independently
Treatment starts at 0.25 mg weekly and increases every four weeks through 0.5 mg, 1.0 mg, and 1.7 mg before reaching the maintenance dose of 2.4 mg per week
It has no effect on clotting, bleeding, or anaesthetic metabolism
Tailored Solutions: We understand that every individual is unique
US$ 22.05
US$ 21.90
US$ 22.51
US$ 68025.00
Sold : Login>>